How the FDA Approval of the Pfizer COVID-19 Vaccine May Impact the Work of Nurses Involved in Ongoing Vaccinations

Melody Butler, BSN, RN, CIC, founding executive director of Nurses Who Vaccinate, discusses the FDA’s completion of its review of the BLA for the Pfizer-BioNTech COVID-19 vaccine, and its potential impact on nurses who are working to support the COVID-19 vaccination process.

Contemporary Clinic interviewed Melody Butler, BSN, RN, CIC, founding executive director of Nurses Who Vaccinate, on the FDA’s completion of its review of the biologics license application for the Pfizer-BioNTech COVID-19 vaccine and its potential impact on nurses who are working to support the COVID-19 vaccination process.

During the discussion, Butler addressed what the final approval of the Pfizer-BioNTech COVID-19 vaccine means for the ongoing vaccination process, whether anything will change for nurses involved in COVID-19 vaccinations with this FDA approval, how nurses have been able to help the country get through the struggles of the past year, and how a nurse interested in getting involved in COVID-19 vaccination efforts might be able to do so.

Related Content